Arnaud Tiberghien

Company: Bicycle Therapeutics

Job title: Associate Director

Seminars:

Bicycle Conjugates for Precision Targeting of Solid Tumors 11:00 am

A novel peptide-based modality consisting of constrained peptides that form a bi-cyclic structure via ligation to a chemical scaffold Discovery using the Bicycle® phage display platform and have potential broad utility, allowing efficient and targeted delivery of different classes of payloads into tumors. Utilising Bicycle molecules are employed as targeting vectors to deliver toxins and…Read more

day: Day Two